3 active not recruiting, 1 completed, 1 unknown. 4 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 3, Unknown 1 |
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
Follow Thomas Hatschek: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors Tamoxifen or Aromatase Inhibitor or Aromatase Inhibitor + goserelin, Palbociclib - Early-Stage Breast Carcinoma, Hormone Receptor Positive Tumor | Phase 2 | Active not recruiting | Thomas Hatschek | 10 | 2015-10-01 | 2020-07-07 |
| Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases Paclitaxel, Tamoxifen + Palbociclib, Aromatase Inhibitor + Palbociclib - Early-Stage Breast Carcinoma, Estrogen Receptor Positive Tumor | Phase 2 | Active not recruiting | Thomas Hatschek | 181 | 2015-02-01 | 2021-08-03 |
| Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer docetaxel + trastuzumab sc + pertuzumab, trastuzumab emtansin - Early-Stage Breast Carcinoma, HER-2 Positive Breast Cancer | Phase 2 / Phase 3 | Active not recruiting | Thomas Hatschek | 202 | 2014-11-01 | 2020-08-13 |
| A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer Early Epirubicin, Docetaxel, Bevacizumab - Breast Cancer | Phase 2 | Unknown | Thomas Hatschek | 151 | 2008-09-01 | 2016-09-08 |
| Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast Cancer Epirubicin, Paclitaxel, Capecitabine - Metastatic Breast Cancer | Phase 3 | Completed | Thomas Hatschek | 304 | 2002-12-01 | 2015-09-17 |
Breast Neoplasms (5) · Inflammatory Breast Neoplasms (1)
Anastrozole (2) · Aromatase Inhibitors (2) · Docetaxel (2) · Epirubicin (2) · Goserelin (2) · Letrozole (2) · Paclitaxel (2) · Tamoxifen (2) · exemestane (2) · palbociclib (2) · Ado-Trastuzumab Emtansine (1) · Bevacizumab (1) · Capecitabine (1) · pertuzumab (1)
Sweden (5)
PMID 19104202, PMID 20680680, PMID 21298494, PMID 22094937, PMID 23322522, PMID 23736998, PMID 24287398, PMID 25361981, PMID 26276891, PMID 27461224, PMID 29078273, PMID 32423477, PMID 34037241, PMID 34165503, PMID 36449695, PMID 38175448, PMID 39729390, PMID 41951647